Medication info
Atovastatin Tablet 10 mg (Atorvastatin Calcium Trihydrate)

Atovastatin Tablet 10 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Ixu Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Approval status
Active

MFDS item code 201502559 · Approved 2015.04.28 · Insurance code 658501720

Summary

Main use
Improvement of hyperlipidemia and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients receiving or about to receive atorvastatin should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients who require greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and in assessing response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg/day of this medicine, and the recommended maximum dose is 20 mg/day (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Ixu Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
  • hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. In particular, it reduces the risk of myocardial infarction, stroke, revascularization, and angina in adults with risk factors for coronary heart disease and patients with type 2 diabetes. It also helps reduce the risk of nonfatal myocardial infarction, stroke, and heart failure hospitalizations in adults with clinical evidence. Additionally, it is used as an adjunctive treatment to reduce levels of total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides while increasing HDL cholesterol in patients with hyperlipidemia. It also improves cholesterol levels in children aged 10 to 17 years with heterozygous familial hypercholesterolemia as an adjunct to dietary therapy. This medication is used to improve cardiovascular risk factors and for the treatment of hyperlipidemia.

Dosage and Administration

Adult dosage

Patients receiving or about to receive atorvastatin should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients who require greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and in assessing response. If LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg/day of this medicine, and the recommended maximum dose is 20 mg/day (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle-related symptoms, so if there is severe muscle pain or weakness, or significantly elevated creatine kinase levels, treatment should be stopped immediately. This medication should not be used in patients with severely impaired liver function or active liver disease, in pregnant or possibly pregnant women, or in breastfeeding women, or in children under 10 years of age. Caution should be taken when using this drug in patients with a history of alcoholism or liver disease, those with impaired kidney function, those with hypothyroidism, and those with a history of muscle disease. Patients taking this medication should undergo regular liver function tests and muscle-related tests, and if symptoms such as nausea, vomiting, fatigue, muscle pain, or fever appear, they should consult a doctor immediately. This medication can interact with several other drugs, so if other medications are being taken, it is essential to inform a doctor or pharmacist, especially when used in conjunction with certain antibiotics, antifungals, antivirals, and immunosuppressants. When taken with grapefruit juice, this medication can increase blood concentration, so excessive intake should be avoided. Women of childbearing potential should use appropriate contraceptive methods while taking this medication and should stop taking it immediately if pregnancy is confirmed. If symptoms such as muscle pain, muscle weakness, fatigue, or fever occur while taking this medication, it is important to notify healthcare personnel and undergo testing. Elderly patients or those with decreased kidney function should be monitored more carefully due to a higher risk of muscle-related side effects. In the case of overdose, there is no specific antidote, so treatment will depend on the symptoms, and liver function and muscle enzyme levels should be monitored. This medication should be kept out of the reach of children and should be stored in its original container for safety.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 91 more
  • loss of appetite
  • constipation
  • abdominal distention
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngalgia
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • sensation abnormalities
  • sensory loss
  • taste abnormalities
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorder
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vasomotor edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased butyrylcholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • hypertriglyceridemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hypertrophy
  • hypothermia
  • sleep disorders
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • elevated AST

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1°C and 30°C at room temperature. This storage will help safely maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.